These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15221601)

  • 1. Surgical resection deteriorates gemcitabine-induced leukopenia in pancreatic cancer.
    Onoue M; Terada T; Okuda M; Fujimoto K; Doi R; Imamura M; Inui K
    Int J Clin Oncol; 2004 Jun; 9(3):174-8. PubMed ID: 15221601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
    Gong JF; Zhang XD; Li J; Di LJ; Jin ML; Shen L
    Ai Zheng; 2007 Aug; 26(8):890-4. PubMed ID: 17697554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in tumor marker levels as a predictor of gemcitabine effect on patients with unresectable or recurrent pancreatic cancer].
    Tendo M; Nakata B; Nishino H; Inoue M; Kosaka K; Amano R; Yamada N; Hirakawa K
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):795-8. PubMed ID: 15984518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study.
    Van Laethem JL; Demols A; Gay F; Closon MT; Collette M; Polus M; Houbiers G; Gastelblum P; Gelin M; Houtte PV; Closset J
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):974-80. PubMed ID: 12829132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine Adjuvant Therapy for Resected Pancreatic Cancer: A Meta-analysis.
    Yu Z; Zhong W; Tan ZM; Wang LY; Yuan YH
    Am J Clin Oncol; 2015 Jun; 38(3):322-5. PubMed ID: 23934134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy.
    Matsui H; Hazama S; Sakamoto K; Shindo Y; Kanekiyo S; Nakashima M; Matsukuma S; Tokuhisa Y; Iida M; Suzuki N; Yoshimura K; Takeda S; Ueno T; Yoshino S; Oka M; Nagano H
    Pancreas; 2017 Sep; 46(8):994-1002. PubMed ID: 28697053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.
    Li Y; Sun J; Jiang Z; Zhang L; Liu G
    J Chemother; 2015 Aug; 27(4):227-34. PubMed ID: 25790948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine or gemcitabine plus cisplatin for in 42 patients with locally advanced or metastatic pancreatic cancer.
    Wang X; Ni Q; Jin M; Li Z; Wu Y; Zhao Y; Feng F
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):404-7. PubMed ID: 12408777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low-dose gemcitabine on unresectable pancreatic cancer in elderly patients.
    Matsumoto K; Miyake Y; Kato H; Kawamoto H; Imagawa A; Toyokawa T; Nakatsu M; Ando M; Hirohata M; Yamamoto K
    Digestion; 2011; 84(3):230-5. PubMed ID: 21860243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine.
    Nakai Y; Isayama H; Kawabe T; Tsujino T; Yoshida H; Sasaki T; Tada M; Arizumi T; Yagioka H; Kogure H; Togawa O; Ito Y; Matsubara S; Hirano K; Sasahira N; Omata M
    Pancreas; 2008 Nov; 37(4):405-10. PubMed ID: 18953253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of S100A4 mRNA in EUS-FNA specimens for the assessment of chemosensitivity to gemcitabine from patients with unresectable pancreatic cancer.
    Ma G; Sun Y; Fu S
    Int J Clin Exp Pathol; 2015; 8(10):13284-8. PubMed ID: 26722531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.
    Poplin E; Feng Y; Berlin J; Rothenberg ML; Hochster H; Mitchell E; Alberts S; O'Dwyer P; Haller D; Catalano P; Cella D; Benson AB
    J Clin Oncol; 2009 Aug; 27(23):3778-85. PubMed ID: 19581537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without impairing patients' quality of life.
    Toyama Y; Yoshida S; Saito R; Kitamura H; Okui N; Miyake R; Ito R; Son K; Usuba T; Nojiri T; Yanaga K
    World J Surg Oncol; 2013 Jan; 11():3. PubMed ID: 23302293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Feasibility and anti-tumor activity of postoperative adjuvant chemotherapy with gemcitabine for resected pancreatic cancer].
    Udaka T; Konishi Y; Waki N; Hayama M; Kubo M; Sogabe O; Maeda H; Mizuta M; Shirakawa K
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):937-40. PubMed ID: 18633220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after chemoradiation in resected pancreatic cancer: the impact of adjuvant gemcitabine.
    Baschnagel A; Shah C; Margolis J; Nadeau L; Stein J; Jury R; Robertson JM
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e331-5. PubMed ID: 22420967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials.
    Jin SF; Fan ZK; Pan L; Jin LM
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):236-244. PubMed ID: 28603091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.
    Ikeda M; Okada S; Tokuuye K; Ueno H; Okusaka T
    Br J Cancer; 2002 May; 86(10):1551-4. PubMed ID: 12085203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
    Yajima T; Furukawa Y; Ishii Y; Hattori Y; Matsumoto N; Yamamoto M; Yamaoka Y; Fujihara M; Fujita M; Kuniki H
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):953-7. PubMed ID: 15222120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma.
    Yamagishi Y; Higuchi H; Izumiya M; Sakai G; Iizuka H; Nakamura S; Adachi M; Hozawa S; Takaishi H; Hibi T
    J Gastroenterol; 2010 Nov; 45(11):1146-54. PubMed ID: 20549255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.
    O'Neil BH; Scott AJ; Ma WW; Cohen SJ; Aisner DL; Menter AR; Tejani MA; Cho JK; Granfortuna J; Coveler L; Olowokure OO; Baranda JC; Cusnir M; Phillip P; Boles J; Nazemzadeh R; Rarick M; Cohen DJ; Radford J; Fehrenbacher L; Bajaj R; Bathini V; Fanta P; Berlin J; McRee AJ; Maguire R; Wilhelm F; Maniar M; Jimeno A; Gomes CL; Messersmith WA
    Ann Oncol; 2015 Sep; 26(9):1923-1929. PubMed ID: 26091808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.